sever
fever
thrombocytopenia
syndrom
sft
emerg
tickmedi
infecti
diseas
recent
discov
rural
area
china
clinic
characterist
diseas
human
primarili
includ
thrombocytopenia
leukocytopenia
high
fever
gastrointestin
symptom
imbalanc
liver
enzym
product
pathogen
respons
sft
sft
viru
sftsv
novel
phleboviru
famili
bunyavirida
viru
contain
three
rna
genom
segment
coat
nucleoprotein
np
encapsul
nm
diamet
glycoprotein
viral
envelop
sinc
first
report
human
sft
central
china
addit
case
report
continu
part
china
korea
japan
patient
diagnos
sft
fatal
rate
diseas
korea
among
viral
pathogen
speci
known
caus
human
diseas
also
infect
vertebr
anim
moreov
seroposit
rate
sftsv
report
domest
anim
china
strongli
suggest
anim
major
reservoir
tickmedi
sftsv
transmiss
addit
seroposit
shrew
rodent
recent
implic
potenti
anim
host
suscept
sftsv
studi
korea
show
sftsvposit
tick
widespread
throughout
provinc
particularli
summer
moreov
recent
evid
shown
sftsv
act
zoonot
pathogen
studi
serolog
preval
farm
wild
anim
speci
necessari
revers
transcriptas
rt
polymeras
chain
reaction
pcr
base
method
conduct
detect
sftsv
antigen
blood
sampl
moreov
immunofluoresc
assay
ifa
frequent
use
detect
sftsvspecif
antibodi
sera
sft
patient
diagnost
method
associ
sever
disadvantag
need
handl
live
viru
requir
special
facil
highlevel
biosafeti
equip
furthermor
method
labori
appli
larg
number
sampl
inhous
indirect
enzymelink
immunosorb
assay
elisa
doubleantigen
sandwich
elisa
develop
detect
immunoglobulin
np
sftsv
report
develop
competit
elisa
celisa
base
competit
sftsvspecif
antibodi
test
serum
monoclon
antibodi
mab
np
sftsv
np
recombin
protein
suitabl
use
diagnost
antigen
highli
immunogen
protein
shown
express
earli
stage
viru
infect
bunyavirida
case
appli
techniqu
field
bovin
sera
experiment
gener
bovin
antisera
sftsv
investig
correl
consist
assay
ifa
celisa
present
studi
use
detect
antibodi
sftsv
cattl
sftsv
isol
human
patient
korea
kindli
provid
korea
center
diseas
control
prevent
kcdc
sftsv
grown
vero
cell
american
type
cultur
collect
usa
accord
previous
describ
method
antigen
product
gene
encod
fulllength
np
protein
sftsv
strain
genbank
access
express
bacteri
overexpress
system
fragment
sftsv
chemic
synthes
use
bioneer
gene
synthesi
servic
bioneer
korea
bp
gene
encod
nprotein
amplifi
use
follow
primer
ctcggaattcacatgtca
gagtggtcc
cttcaagcttcaggtt
cctgtaagcag
pcr
amplif
perform
use
thermocycl
biometra
germani
np
gene
clone
invitrogen
usa
use
bamhi
xhoi
restrict
enzym
new
england
biolab
uk
subsequ
transform
escherichia
coli
yeastern
biotech
taiwan
express
fusion
protein
follow
induct
mm
isopropyl
amresco
usa
h
bacteri
cell
pellet
sonic
chromatographi
buffer
mm
sodium
phosphat
mm
nacl
urea
mm
imidazol
ph
purifi
use
ninta
agaros
qiagen
germani
affinitypurifi
protein
urea
gradient
dialyz
prior
use
recombin
np
protein
solubil
urea
buffer
exchang
mm
trishcl
intron
biotechnolog
korea
use
subsequ
experi
anim
experi
conduct
accord
protocol
institut
anim
care
use
committe
republ
korea
rabbit
polyclon
antibodi
mous
mab
gener
four
immun
recombin
np
polyclon
antibodi
produc
rabbit
four
inject
np
antigen
mix
adjuv
twoweek
interv
npspecif
mab
synthes
previous
describ
briefli
eight
mice
inject
four
time
recombin
np
follow
immun
mous
spleen
cell
collect
fuse
myeloma
cell
gener
mab
among
mous
hybridoma
cell
line
clone
select
accord
specif
interact
np
use
indirect
elisa
cattl
immun
inject
formalininactiv
sftsv
briefli
ml
sftsv
inactiv
use
formalin
solut
h
inactiv
viru
concentr
fivefold
via
filtrat
use
ultracel
millipor
germani
loss
viral
infect
confirm
cultur
vero
cell
two
cattl
age
month
use
produc
posit
control
sera
sftsv
approxim
ml
inactiv
sftsv
emulsifi
gelbas
adjuv
cattl
receiv
intramuscular
inject
everi
week
total
three
inject
serum
sampl
collect
week
last
antigen
inject
serum
use
neg
control
ifa
celisa
collect
cattl
prior
immun
ifa
perform
previous
describ
slight
modif
briefli
vero
cell
grown
confluenc
infect
ml
sftsv
day
infect
cell
cell
per
well
spot
onto
microscop
slide
reaction
well
paul
marienfeld
germani
cell
immedi
fix
methanol
aceton
solut
min
nonspecif
signal
block
hors
serum
total
volum
per
well
cell
incub
mous
mab
specif
polyclon
rabbit
sera
field
bovin
serum
sampl
h
room
temperatur
follow
detect
use
fluorescein
isothiocyan
fitc
label
secondari
antibodi
fitcconjug
antimous
rabbit
bovin
antibodi
kpl
usa
dilut
concentr
prior
use
cell
observ
use
nikon
fluoresc
microscop
nikon
japan
celisa
perform
previous
describ
slight
modif
briefli
polysorp
elisa
plate
nunc
usa
coat
ngwell
recombin
np
plate
incub
hour
allow
antigen
bind
wash
tween
sigmaaldrich
usa
pb
remov
unbound
antigen
plate
block
skim
milk
hors
serum
pb
serolog
test
dilut
test
sera
amount
hrpconjug
mab
ad
antigen
coat
plate
incub
min
mab
conjug
hrp
accord
instruct
provid
ezlinktm
plu
activ
peroxidas
kit
thermo
fisher
scientif
usa
wash
plate
six
time
peroxidas
substrat
kpl
ad
develop
color
reaction
termin
sulfur
acid
sigmaaldrich
optic
densiti
od
sampl
calcul
follow
od
nm
subtract
od
nm
adjust
background
absorb
od
valu
convert
percent
inhibit
pi
valu
use
follow
formula
pi
od
test
sampleod
neg
control
bovin
field
serum
sampl
n
collect
breed
cattl
southern
part
korea
gyeongsang
provinc
septemb
august
celisa
conduct
use
antisera
differ
virus
bovin
viral
diarrhea
bvd
type
viru
neutral
posit
control
serum
bvd
type
viru
neutral
posit
control
serum
nation
veterinari
servic
laboratori
usa
bovin
coronaviru
bovin
rotaviru
bovin
leukemia
viru
akaban
viru
gener
anim
plant
quarantin
agenc
korea
posit
neg
group
compar
oneway
anova
mannwhitney
rank
sum
test
p
valu
indic
signific
differ
group
systat
ver
systat
softwar
usa
bee
swarm
box
plot
indic
distribut
neg
posit
group
gener
use
onlin
applic
graph
receiv
oper
characterist
roc
curv
gener
use
excel
graph
function
gene
recombin
np
amplifi
commerci
synthes
fragment
sftsv
genbank
access
clone
protein
express
vector
kda
recombin
protein
band
well
maintain
purif
procedur
fig
recombin
np
use
antigen
gener
polyclon
mab
npspecif
polyclon
antibodi
obtain
rabbit
four
antigen
immun
titer
antibodi
test
ifa
western
blot
fig
npspecif
mab
produc
spleen
hybridoma
cell
immun
mice
three
clone
show
strong
interact
ifa
western
blot
test
therefor
clone
use
competit
antibodi
develop
celisa
clear
band
correspond
size
np
appear
sftsv
infect
observ
upon
western
blot
analysi
gener
antibodi
panel
fig
moreov
ifa
use
antibodi
show
intens
cytoplasm
stain
specif
sftsvinfect
vero
cell
panel
b
fig
sftsvposit
cattl
sera
gener
two
cattl
inject
three
time
inactiv
sftsv
serial
dilut
posit
neg
serum
sampl
test
determin
optim
dilut
rate
distinguish
sftsvposit
serum
sampl
neg
sampl
ifa
maximum
dilut
rate
serum
ifa
nonspecif
background
signal
observ
neg
control
fig
elisa
plate
coat
differ
concentr
antigen
use
determin
optim
coat
antigen
concentr
supplementari
fig
among
mab
clone
screen
base
igg
respons
ifa
western
blot
test
select
competit
antibodi
celisa
mab
show
stabl
reactiv
conjug
horseradish
peroxidas
hrp
protein
dilut
mabperoxidas
conjug
yield
maximum
percent
inhibit
rate
celisa
supplementari
fig
immun
cattl
serum
sampl
test
celisa
dilut
posit
serum
sampl
show
higher
pi
valu
neg
serum
howev
dilut
posit
control
sera
yield
larg
differ
optic
densiti
od
posit
neg
serum
sampl
fig
repeat
find
confirm
three
independ
experi
specif
sftsv
celisa
examin
use
antisera
differ
type
virus
cattl
maximum
pi
valu
laboratoryimmun
bovin
serum
celisa
antisera
differ
virus
bvd
type
bvd
type
bovin
coronaviru
bovin
rotaviru
bovin
leukemia
viru
akaban
viru
yield
pi
valu
supplementari
fig
find
demonstr
celisa
highli
specif
detect
antibodi
sftsv
total
bovin
serum
sampl
two
posit
control
sera
test
ifa
distinguish
neg
serum
sampl
sftsv
result
show
bovin
serum
sampl
neg
bovin
serum
sampl
posit
accord
ifa
celisa
perform
use
sftsneg
group
sampl
mean
inhibit
percent
standard
deviat
therefor
determin
cutoff
valu
mean
fig
celisa
ifa
compar
use
cutoff
valu
consist
observ
result
tabl
accuraci
celisa
demonstr
plot
distribut
pi
valu
obtain
ifaneg
posit
cattl
group
fig
offici
standard
method
antibodi
detect
sftsv
determin
cutoff
criteria
determin
ifa
requir
optim
therefor
roc
curv
employ
determin
sensit
specif
defin
optim
cutoff
valu
ifa
roc
curv
four
differ
ifa
cutoff
valu
compar
result
show
dilut
sampl
strongli
support
result
celisa
dilut
area
curv
auc
dilut
rate
ifa
cutoff
point
maxim
specif
sensit
compar
dilut
rate
condit
strict
detect
posit
sampl
strict
threshold
celisa
ifa
cutoff
condit
also
exclud
show
moder
auc
valu
fig
use
dilut
cutoff
ifa
pi
cutoff
celisa
bovin
serum
sampl
identifi
posit
serum
sampl
neg
tickmedi
sftsv
emerg
infecti
viru
identifi
show
lethal
human
howev
rang
host
speci
viru
circul
rout
environ
difficult
determin
standard
diagnosi
method
avail
therefor
simpl
effect
method
detect
sftsv
antibodi
need
identifi
potenti
host
develop
antivir
strategi
effort
detect
sftsvspecif
antibodi
inhous
elisa
doubleantigen
sandwich
elisa
daselisa
assay
develop
specif
daselisa
use
determin
seropreval
human
anim
china
multiplex
luminexbas
immunoassay
method
also
establish
highthroughput
detect
newli
develop
techniqu
highli
specif
sensit
commerci
avail
method
requir
special
equip
diagnosi
report
develop
celisa
use
mab
detect
antibodi
sftsv
celisa
format
select
serodiagnost
test
valu
handl
field
serum
sampl
requir
small
volum
serum
diagnosi
show
speci
flexibl
immunostain
western
blot
use
detect
mab
high
affin
sftsvinfect
vero
cell
result
indic
gener
mab
appropri
use
develop
celisa
previou
studi
show
involv
domest
anim
husbandri
signific
factor
sftsv
infect
compar
outdoor
activ
tick
exposur
china
therefor
collect
field
bovin
sera
farm
gyeongsang
provinc
korea
human
sftsv
infect
report
first
test
field
bovin
serum
sampl
use
ifa
bovin
serum
sampl
yield
neg
result
ifa
use
neg
group
determin
cutoff
valu
celisa
field
serum
sampl
two
experiment
immun
bovin
sera
examin
immun
respons
sftsv
use
ifa
celisa
result
show
total
serum
sampl
yield
neg
result
ifa
therefor
group
regard
neg
sftsv
celisa
cutoff
valu
subsequ
calcul
use
mean
inhibit
rate
ifaneg
popul
cutoff
pi
use
cutoff
ifaneg
bovin
serum
sampl
also
consid
neg
celisa
although
newli
develop
celisa
highli
specif
field
anim
infect
sftsv
would
need
measur
improv
sensit
sftsv
first
isol
goat
antibodi
sftsv
detect
sera
obtain
goat
one
goat
farm
southern
part
korea
gyeongsang
provinc
septemb
person
commun
dr
lee
yoonhe
mr
choi
jeongsoo
foreign
anim
diseas
divis
anim
plant
quarantin
agenc
korea
serolog
diagnost
method
necessari
test
larg
number
anim
celisa
develop
present
studi
requir
addit
test
valid
perform
result
observ
date
promis
studi
adapt
diagnost
techniqu
broad
spectrum
anim
speci
current
progress
